Endpoint Determination

"Endpoint Determination" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Establishment of the level of a quantifiable effect indicative of a biologic process. The evaluation is frequently to detect the degree of toxic or therapeutic effect.

Descriptor ID	D023381
MeSH Number(s)	E05.315
Concept/Terms	Endpoint Determination Endpoint Determination Determination, Endpoint Determinations, Endpoint Endpoint Determinations End Point Determination Determinations, End Point End Point Determinations Point Determinations, End Endpoint Assay Endpoint Assay Assay, Endpoint Assays, Endpoint Endpoint Assays End Point Assay Assay, End Point Assays, End Point End Point Assays Point Assay, End Point Assays, End

Below are MeSH descriptors whose meaning is more general than "Endpoint Determination".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Investigative Techniques [E05]
Endpoint Determination [E05.315]

Below are MeSH descriptors whose meaning is related to "Endpoint Determination".

Below are MeSH descriptors whose meaning is more specific than "Endpoint Determination".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Endpoint Determination" by people in this website by year, and whether "Endpoint Determination" was a major or minor topic of these publications.

Bar chart showing 7 publications over 6 distinct years, with a maximum of 2 publications in 2015

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2009	0	1	1
2013	0	1	1
2014	0	1	1
2015	1	1	2
2016	0	1	1
2020	0	1	1

Below are the most recent publications written about "Endpoint Determination" by people in Profiles.

Carlson LM, Champagne FA, Cory-Slechta DA, Dishaw L, Faustman E, Mundy W, Segal D, Sobin C, Starkey C, Taylor M, Makris SL, Kraft A. Potential frameworks to support evaluation of mechanistic data for developmental neurotoxicity outcomes: A symposium report. Neurotoxicol Teratol. 2020 Mar - Apr; 78:106865.

View in: PubMed
Kar S, Gajewicz A, Roy K, Leszczynski J, Puzyn T. Extrapolating between toxicity endpoints of metal oxide nanoparticles: Predicting toxicity to Escherichia coli and human keratinocyte cell line (HaCaT) with Nano-QTTR. Ecotoxicol Environ Saf. 2016 Apr; 126:238-244.

View in: PubMed
Lum F, Tarver ME, Kahook MY, Oetting TA, Rorer E, Hilmantel G, Calogero D, Kiang T, Berdahl JP, Coleman AL, Eydelman MB. Special Commentary: Food and Drug Administration and American Academy of Ophthalmology Sponsored: Developing Novel End Points for Premium Intraocular Lenses Workshop. Ophthalmology. 2015 Jul; 122(7):1522-31.

View in: PubMed
Givertz MM, Anstrom KJ, Redfield MM, Deswal A, Haddad H, Butler J, Tang WH, Dunlap ME, LeWinter MM, Mann DL, Felker GM, O'Connor CM, Goldsmith SR, Ofili EO, Saltzberg MT, Margulies KB, Cappola TP, Konstam MA, Semigran MJ, McNulty SE, Lee KL, Shah MR, Hernandez AF. Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study. Circulation. 2015 May 19; 131(20):1763-71.

View in: PubMed
Gajewicz A, Cronin MT, Rasulev B, Leszczynski J, Puzyn T. Novel approach for efficient predictions properties of large pool of nanomaterials based on limited set of species: nano-read-across. Nanotechnology. 2015 Jan 09; 26(1):015701.

View in: PubMed
Zangwill LM, Jain S, Dirkes K, He F, Medeiros FA, Trick GL, Brandt JD, Cioffi GA, Coleman AL, Liebmann JM, Piltz-Seymour JR, Gordon MO, Kass MA, Weinreb RN. The rate of structural change: the confocal scanning laser ophthalmoscopy ancillary study to the ocular hypertension treatment study. Am J Ophthalmol. 2013 Jun; 155(6):971-82.

View in: PubMed
Forchhammer L, Ersson C, Loft S, M?ller L, Godschalk RW, van Schooten FJ, Jones GD, Higgins JA, Cooke M, Mistry V, Karbaschi M, Collins AR, Azqueta A, Phillips DH, Sozeri O, Routledge MN, Nelson-Smith K, Riso P, Porrini M, Matullo G, Allione A, Stepnik M, Steepnik M, Komorowska M, Teixeira JP, Costa S, Corcuera LA, L?pez de Cerain A, Laffon B, Valdiglesias V, M?ller P. Inter-laboratory variation in DNA damage using a standard comet assay protocol. Mutagenesis. 2012 Nov; 27(6):665-72.

View in: PubMed
Coleman AL, Caprioli J. The logic behind target intraocular pressure. Am J Ophthalmol. 2009 Mar; 147(3):379-80.

View in: PubMed
Calian V, Li D, Hsu JC. Partitioning to uncover conditions for permutation tests to control multiple testing error rates. Biom J. 2008 Oct; 50(5):756-66.

View in: PubMed

People

Explore

Similar Concepts

Top Journals